These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 9566028

  • 1. Involvement of 5-hydroxytryptamine 2A (5-HT2A) receptors in the mediation of the discriminative stimulus properties of (+/-)DOI in rats.
    Chojnacka-Wójcik E, Kłodzińska A.
    Pol J Pharmacol; 1997; 49(5):299-304. PubMed ID: 9566028
    [Abstract] [Full Text] [Related]

  • 2. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [Abstract] [Full Text] [Related]

  • 3. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M, McCreary AC, Przegaliński E, Filip M.
    Eur J Pharmacol; 2007 Oct 01; 571(2-3):156-65. PubMed ID: 17617403
    [Abstract] [Full Text] [Related]

  • 4. Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in the generalization of 5-HT receptor agonists to the ethanol cue in the rat.
    Maurel S, Schreiber R, De Vry J.
    Behav Pharmacol; 1998 Jul 01; 9(4):337-43. PubMed ID: 10065922
    [Abstract] [Full Text] [Related]

  • 5. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM, Cunningham KA.
    Eur J Pharmacol; 1994 May 12; 257(1-2):27-38. PubMed ID: 8082704
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 12; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 7. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
    Sánchez H, Velázquez-Martínez DN.
    J Psychopharmacol; 2001 Mar 12; 15(1):29-36. PubMed ID: 11277605
    [Abstract] [Full Text] [Related]

  • 8. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists.
    Batman AM, Munzar P, Beardsley PM.
    Psychopharmacology (Berl); 2005 May 12; 179(2):393-401. PubMed ID: 15565434
    [Abstract] [Full Text] [Related]

  • 9. Differential involvement of 5-HT(2A) receptors in the discriminative-stimulus effects of cocaine and methamphetamine.
    Munzar P, Justinova Z, Kutkat SW, Goldberg SR.
    Eur J Pharmacol; 2002 Feb 01; 436(1-2):75-82. PubMed ID: 11834249
    [Abstract] [Full Text] [Related]

  • 10. Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice.
    Smith RL, Barrett RJ, Sanders-Bush E.
    Psychopharmacology (Berl); 2003 Feb 01; 166(1):61-8. PubMed ID: 12474110
    [Abstract] [Full Text] [Related]

  • 11. Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors.
    Callahan PM, Cunningham KA.
    J Pharmacol Exp Ther; 1995 Sep 01; 274(3):1414-24. PubMed ID: 7562516
    [Abstract] [Full Text] [Related]

  • 12. Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task.
    Koskinen T, Ruotsalainen S, Puumala T, Lappalainen R, Koivisto E, Männistö PT, Sirviö J.
    Neuropharmacology; 2000 Jan 28; 39(3):471-81. PubMed ID: 10698013
    [Abstract] [Full Text] [Related]

  • 13. Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats.
    Asgari K, Body S, Bak VK, Zhang ZQ, Rickard JF, Glennon JC, Fone KC, Bradshaw CM, Szabadi E.
    Behav Pharmacol; 2006 Feb 28; 17(1):51-9. PubMed ID: 16377963
    [Abstract] [Full Text] [Related]

  • 14. Lack of cross-tolerance for hypophagia induced by DOI versus m-CPP suggests separate mediation by 5-HT2A and 5-HT2C receptors, respectively.
    Aulakh CS, Mazzola-Pomietto P, Hulihan-Giblin BA, Murphy DL.
    Neuropsychopharmacology; 1995 Aug 28; 13(1):1-8. PubMed ID: 8526967
    [Abstract] [Full Text] [Related]

  • 15. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
    Willins DL, Meltzer HY.
    J Pharmacol Exp Ther; 1997 Aug 28; 282(2):699-706. PubMed ID: 9262333
    [Abstract] [Full Text] [Related]

  • 16. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ, Aghajanian GK.
    J Pharmacol Exp Ther; 1996 Sep 28; 278(3):1373-82. PubMed ID: 8819525
    [Abstract] [Full Text] [Related]

  • 17. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Marona-Lewicka D, Thisted RA, Nichols DE.
    Psychopharmacology (Berl); 2005 Jul 28; 180(3):427-35. PubMed ID: 15723230
    [Abstract] [Full Text] [Related]

  • 18. Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes.
    McCreary AC, Filip M, Cunningham KA.
    Behav Neurosci; 2003 Apr 28; 117(2):212-21. PubMed ID: 12708517
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor.
    Smith RL, Barrett RJ, Sanders-Bush E.
    Psychopharmacology (Berl); 1999 Jun 28; 144(3):248-54. PubMed ID: 10435391
    [Abstract] [Full Text] [Related]

  • 20. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J, Hanniford D, Doucette C, Graham E, Poole MF, Ting A, Sherf B, Harrington J, Brunden K, Stricker-Krongrad A.
    Assay Drug Dev Technol; 2005 Dec 28; 3(6):649-59. PubMed ID: 16438660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.